These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 17476086)

  • 1. Use of a pediatric end-stage liver disease score for deceased donor allocation: the United States experience.
    McDiarmid SV; Merion RM; Dykstra DM; Harper AM
    Indian J Pediatr; 2007 Apr; 74(4):387-92. PubMed ID: 17476086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. National and regional analysis of exceptions to the Pediatric End-Stage Liver Disease scoring system (2003-2004).
    Shneider BL; Suchy FJ; Emre S
    Liver Transpl; 2006 Jan; 12(1):40-5. PubMed ID: 16382460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Critical analysis of the pediatric end-stage liver disease scoring system: a single center experience.
    Shneider BL; Neimark E; Frankenberg T; Arnott L; Suchy FJ; Emre S
    Liver Transpl; 2005 Jul; 11(7):788-795. PubMed ID: 15973720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving liver allocation: MELD and PELD.
    Freeman RB; Wiesner RH; Roberts JP; McDiarmid S; Dykstra DM; Merion RM
    Am J Transplant; 2004; 4 Suppl 9():114-31. PubMed ID: 15113360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of the Pediatric End-Stage Liver Disease (PELD) growth failure thresholds on mortality among pediatric liver transplant candidates.
    Swenson SM; Roberts JP; Rhee S; Perito ER
    Am J Transplant; 2019 Dec; 19(12):3308-3318. PubMed ID: 31370108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MELD scores of liver transplant recipients according to size of waiting list: impact of organ allocation and patient outcomes.
    Trotter JF; Osgood MJ
    JAMA; 2004 Apr; 291(15):1871-4. PubMed ID: 15100206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of a continuous disease severity score to the OPTN liver waiting list.
    Edwards EB; Harper AM
    Clin Transpl; 2001; ():19-24. PubMed ID: 12211782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. International normalized ratio of prothrombin time in the model for end-stage liver disease score: an unreliable measure.
    Arjal R; Trotter JF
    Clin Liver Dis; 2009 Feb; 13(1):67-71. PubMed ID: 19150311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a pediatric end-stage liver disease score to predict poor outcome in children awaiting liver transplantation.
    McDiarmid SV; Anand R; Lindblad AS;
    Transplantation; 2002 Jul; 74(2):173-81. PubMed ID: 12151728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overview of the MELD/PELD system of liver allocation indications for liver transplantation in the MELD era: evidence-based patient selection.
    Freeman RB
    Liver Transpl; 2004 Oct; 10(10 Suppl 2):S2-3. PubMed ID: 15382218
    [No Abstract]   [Full Text] [Related]  

  • 11. The pediatric end-stage liver disease (PELD) model as a predictor of survival benefit and posttransplant survival in pediatric liver transplant recipients.
    Barshes NR; Lee TC; Udell IW; O'mahoney CA; Karpen SJ; Carter BA; Goss JA
    Liver Transpl; 2006 Mar; 12(3):475-80. PubMed ID: 16498644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The value of MELD in the allocation of priority for liver transplantation candidates].
    Colmenero J; Castro-Narro G; Navasa M
    Gastroenterol Hepatol; 2010 Apr; 33(4):330-6. PubMed ID: 19631411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyponatremia and mortality among patients on the liver-transplant waiting list.
    Kim WR; Biggins SW; Kremers WK; Wiesner RH; Kamath PS; Benson JT; Edwards E; Therneau TM
    N Engl J Med; 2008 Sep; 359(10):1018-26. PubMed ID: 18768945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MELD and PELD: application of survival models to liver allocation.
    Wiesner RH; McDiarmid SV; Kamath PS; Edwards EB; Malinchoc M; Kremers WK; Krom RA; Kim WR
    Liver Transpl; 2001 Jul; 7(7):567-80. PubMed ID: 11460223
    [No Abstract]   [Full Text] [Related]  

  • 15. The impact of PELD on OPTN liver allocation: preliminary results.
    Davies DB
    Clin Transpl; 2003; ():13-20. PubMed ID: 15387095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Model for end-stage liver disease: impact of the new deceased donor liver allocation policy in São Paulo, Brazil.
    Monteiro F; Coria SA; Boni R; Pereira LA
    Transplant Proc; 2009; 41(1):226-8. PubMed ID: 19249520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selection of pediatric candidates under the PELD system.
    McDiarmid SV; Merion RM; Dykstra DM; Harper AM
    Liver Transpl; 2004 Oct; 10(10 Suppl 2):S23-30. PubMed ID: 15384170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reply: geographic disparities and deceased donor liver transplantation within a single UNOS region.
    Goss JA; Barshes NR; Washburn WK
    Liver Transpl; 2007 Dec; 13(12):1760; author reply 1761. PubMed ID: 18044781
    [No Abstract]   [Full Text] [Related]  

  • 19. The influence of laboratory-induced MELD score differences on liver allocation: more reality than myth.
    Schouten JN; Francque S; Van Vlierberghe H; Colle I; Nevens F; Delwaide J; Adler M; Starkel P; Ysebaert D; Gadisseur A; De Winter B; Smits JM; Rahmel A; Michielsen P
    Clin Transplant; 2012; 26(1):E62-70. PubMed ID: 22032173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver transplantation in the era of model for end-stage liver disease.
    Wang VS; Saab S
    Liver Int; 2004 Feb; 24(1):1-8. PubMed ID: 15101994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.